A Medical Device Daily

AxoGen (Alachua, Florida) reported an exclusive agreement with Stryker Orthopaedics (Kalamazoo, Michigan) to provide distribution and co-marketing services for the new Avance Nerve Graft.

Stryker will be responsible for Avance Nerve Graft distribution services for nerve repairs in the upper extremities, lower extremities and brachial plexus. AxoGen will provide distribution services within the head, neck and torso. Avance Nerve Graft is intended for use in the repair of damaged and diseased peripheral nerves.

The companies said that the deal will unite the marketing forces of Stryker Orthopaedics with the first commercially available, off-the-shelf nerve-to-nerve repair option.

“This partnership represents a milestone achievement for our organization,” said John Engels, VP for AxoGen.

Stryker develops implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries.

AxoGen develops devices for patients with peripheral nerve injuries.